GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grapefruit USA Inc (OTCPK:GPFT) » Definitions » EV-to-EBIT

Grapefruit USA (Grapefruit USA) EV-to-EBIT : -60.66 (As of May. 25, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Grapefruit USA EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Grapefruit USA's Enterprise Value is $6.49 Mil. Grapefruit USA's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.11 Mil. Therefore, Grapefruit USA's EV-to-EBIT for today is -60.66.

The historical rank and industry rank for Grapefruit USA's EV-to-EBIT or its related term are showing as below:

GPFT' s EV-to-EBIT Range Over the Past 10 Years
Min: -151.4   Med: -1.14   Max: 14.09
Current: -60.66

During the past 13 years, the highest EV-to-EBIT of Grapefruit USA was 14.09. The lowest was -151.40. And the median was -1.14.

GPFT's EV-to-EBIT is ranked worse than
100% of 670 companies
in the Drug Manufacturers industry
Industry Median: 17.12 vs GPFT: -60.66

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Grapefruit USA's Enterprise Value for the quarter that ended in Sep. 2023 was $7.81 Mil. Grapefruit USA's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.11 Mil. Grapefruit USA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -1.37%.


Grapefruit USA EV-to-EBIT Historical Data

The historical data trend for Grapefruit USA's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grapefruit USA EV-to-EBIT Chart

Grapefruit USA Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.03 -0.40 -9.17 -24.35 -4.24

Grapefruit USA Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Sep23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.24 -6.93 -4.98 -3.88 -73.01

Competitive Comparison of Grapefruit USA's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Grapefruit USA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grapefruit USA's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grapefruit USA's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Grapefruit USA's EV-to-EBIT falls into.



Grapefruit USA EV-to-EBIT Calculation

Grapefruit USA's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=6.491/-0.107
=-60.66

Grapefruit USA's current Enterprise Value is $6.49 Mil.
Grapefruit USA's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Grapefruit USA  (OTCPK:GPFT) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Grapefruit USA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2023 ) =EBIT / Enterprise Value (Q: Sep. 2023 )
=-0.107/7.812446
=-1.37 %

Grapefruit USA's Enterprise Value for the quarter that ended in Sep. 2023 was $7.81 Mil.
Grapefruit USA's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Grapefruit USA EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Grapefruit USA's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Grapefruit USA (Grapefruit USA) Business Description

Traded in Other Exchanges
N/A
Address
10866 Wilshire Boulevard, Suite 225, Los Angeles, CA, USA, 90024
Grapefruit USA Inc manufactures and distributes cannabis-based products. Its extraction lab produces high-quality distillate or Honey Oil from trim that Grapefruit sources through its Distribution arm. The company is a premier licensed Distributor of all things cannabis throughout the State of California. It serves licensed Medicinal and Recreational Dispensaries. Its patented product is Hourglass Cream. Grapefruit owns and operates a California-licensed cannabis extraction laboratory and wholesale distribution facility in the Coachillin' Canna-Business Park near Palm Springs, California.
Executives
Bradley J Yourist director, 10 percent owner, officer: Chairman and CEO 10866 WILSHIRE BLVD, #225, LOS ANGELES CA 90024
Daniel J. Yourist director, 10 percent owner, officer: Board of Directors and COO 10866 WILSHIRE BLVD, SUITE 225, LOS ANGELES CA 90024
Dane Medley director, officer: CEO/Chairman 10553 CAMARILLO STREET, TOLUCA LAKE CA 91602
Emilio Xavier Aguilera director, officer: Chief Financial Officer 16827 HALSEY STREET, GRANADA HILLS CA 91344
Dean Janes officer: CHIEF EXECUTIVE OFFICER 3200 W. VALHALLA DRIVE, BURBANK CA 91505
Christopher Sohn director, officer: President and COO 3200 W. VALHALLA DRIVE, BURBANK CA 91505
Xavier Aguilera director, officer: CFO/Treasurer,Exec.V.P.& Secy 3200 W. VALHALLA DRIVE, BURBANK CA 91505
Michele Janes officer: Vice President of Admin. 3200 W. VALHALLA DRIVE, BURBANK CA 91505

Grapefruit USA (Grapefruit USA) Headlines

From GuruFocus

Grapefruit's 'Summit Boys' Brand Goes Mobile on Blitzdirect.com

By GuruFocusNews GuruFocusNews 04-04-2022

Grapefruit USA, Inc. Update on Hourglass Health Canada NNCP Submission

By GuruFocusNews GuruFocusNews 03-03-2022

Grapefruit USA, Inc. Issues Update on Proposed Strategic Acquisition

By GuruFocusNews GuruFocusNews 05-19-2022